跳至主要内容
临床试验/DRKS00032918
DRKS00032918招募中不适用

Evaluation of SARS-CoV-2-specific Serum parameter in Blood of Patients with present post COVID (VANCOV-01)

VANUDIS GmbH0 个研究点目标入组 60 人开始时间: 2023年10月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Signed informed consent
  • -Ability to consent
  • -Confirmed infection with Corona virus SARS-CoV-2
  • -Confirmed infection not older than 18 months
  • -No severe chronic underlying disease at the time-point of SARS-CoV-2 infection

排除标准

  • -Any disease or condition which does not allow blood-sampling (jugded by the study investigator)
  • -severe chronic disease which was present before SARS-CoV-2 infection
  • -prior Plasmapheresis or Immuno-adsorption procedures
  • -Current smoker or ex-smoker (<5 years)

研究者

发起方
VANUDIS GmbH

相似试验